LABETALOL HYDROCHLORIDE | A075113 | AIPING PHARMACEUTICAL INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition Amendment from Hyman, Phelps & McNamara, P.C. FDA-2025-P-7056 · 9 docket documents Hyman, Phelps & McNamara, P.C. filed a suitability petition amendment, though the specific drug product, requested regulatory action, and detailed petition content are not described in the provided text excerpt. | Suitability | 2026-07-02 | DeniedDecision letter not yet read | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.